2024    2023    2022    2021    2020    2019    2018    2017    2016   

2016

Articles

201 - 

Validation of the high-performance of pyrosequencing for clinical MGMT testing on a cohort of glioblastoma patients from a prospective dedicated multicentric trial

Véronique Quillien, Audrey Lavenu, François Ducray, Marie-Odile Joly, Olivier Chinot et al.

Oncotarget, 2016, 7 (38), pp.61916-61929.

DOI : https://doi.org/10.18632/oncotarget.11322

Pubmed : 27542245

 

202 - 

Validation of the Meaf Score and Comparaison with Early Allograft Dysfunction Critera on Predicting 3 Months Graft Survival

M. Rayar, G. B. Levi Sandri, C. Cusumano, N. Lombard, M. Lakehal et al.

Liver Transplantation, 2016, 22 (6), pp.859-860.

DOI : https://doi.org/10.1002/lt.24405

Pubmed : 26824359

 

203 - 

Multimodal therapy including yttrium-90 radioembolization as a bridging therapy to liver transplantation for a huge and locally advanced intrahepatic cholangiocarcinoma

M. Rayar, G.B. Levi Sandri, P. Houssel-Debry, C. Camus, L. Sulpice et al.

Journal of Gastrointestinal and Liver Diseases, 2016, 25 (3), pp.401--404.

DOI : https://doi.org/10.15403/jgld.2014.1121.253.y90

Pubmed : 27689207

 

204 - 

Risk analysis of ischemic-type biliary lesions after liver transplant using octogenarian donors

Michel Rayar, Giovanni Battista Levi Sandri, Caterina Cusumano, Pauline Houssel-Debry, Christophe Camus et al.

Liver Transplantation, 2016, 22 (9), pp.1301--1302.

DOI : https://doi.org/10.1002/lt.24482

Pubmed : 27197713

 

205 - 

Association Between Transcatheter Aortic Valve Replacement and Subsequent Infective Endocarditis and In-Hospital Death

Ander Regueiro, Axel Linke, Azeem Latib, Nikolaj Ihlemann, Marina Urena et al.

Journal of the American Medical Association, 2016, 316 (10), pp.1083--1092.

DOI : https://doi.org/10.1001/jama.2016.12347

Pubmed : 27623462

 

206 - 

New in vitro and in vivo models to evaluate antibiotic efficacy in Staphylococcus aureus prosthetic vascular graft infection

Matthieu Revest, C. Jacqueline, R. Boudjemaa, J. Caillon, V. Le Mabecque et al.

Journal of Antimicrobial Chemotherapy, 2016, 71 (5), pp.1291-1299.

DOI : https://doi.org/10.1093/jac/dkv496

Pubmed : 26851611

 

207 - 

Adjuvant corticosteroids for patients hospitalized with community-acquired pneumonia: is it time?

Matthieu Revest, Gérald Egmann, Anthony Chapron, Stéphane Jouneau, Pierre Tattevin et al.

Journal of Thoracic Disease, 2016, 8 (5), pp.E288--291.

DOI : https://doi.org/10.21037/jtd.2016.03.34

Pubmed : 27162684

 

208 - 

HACEK endocarditis: state-of-the-art

Matthieu Revest, Gérald Egmann, Vincent Cattoir, Pierre Tattevin

Expert Review of Anti-infective Therapy, 2016, 14 (5), pp.523-530.

DOI : https://doi.org/10.1586/14787210.2016.1164032

Pubmed : 26953488

 

209 - 

Rituximab and dose-dense chemotherapy for adults with Burkitt's lymphoma: a randomised, controlled, open-label, phase 3 trial

Vincent Ribrag, Serge Koscielny, Jacques Bosq, Thibaut Leguay, Olivier Casasnovas et al.

The Lancet, 2016, 387 (10036), pp.2402 - 2411.

DOI : https://doi.org/10.1016/S0140-6736(15)01317-3

Pubmed : 27080498

 

210 - 

Moderate influenza vaccine effectiveness against hospitalisation with A(H3N2) and A(H1N1) influenza in 2013–14: Results from the InNHOVE network

M. Rondy, J. Castilla, O. Launay, S. Costanzo, C. Ezpeleta et al.

Human Vaccines & Immunotherapeutics, 2016, 12 (5), pp.1217--1224.

DOI : https://doi.org/10.1080/21645515.2015.1126013

Pubmed : 27065000